
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID
Michael J. Peluso, Tyler‐Marie Deveau, Sadie E. Munter, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 31
Michael J. Peluso, Tyler‐Marie Deveau, Sadie E. Munter, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
Long COVID: major findings, mechanisms and recommendations
Hannah Davis, Lisa McCorkell, Julia Moore Vogel, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 3, pp. 133-146
Open Access | Times Cited: 2592
Hannah Davis, Lisa McCorkell, Julia Moore Vogel, et al.
Nature Reviews Microbiology (2023) Vol. 21, Iss. 3, pp. 133-146
Open Access | Times Cited: 2592
Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC)
Sindhu Mohandas, Prasanna Jagannathan, Timothy J. Henrich, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 59
Sindhu Mohandas, Prasanna Jagannathan, Timothy J. Henrich, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 59
Pathophysiological, immunological, and inflammatory features of long COVID
Karen Böhmwald, Benjamín Diethelm‐Varela, Linmar Rodríguez-Guilarte, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 17
Karen Böhmwald, Benjamín Diethelm‐Varela, Linmar Rodríguez-Guilarte, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 17
Long COVID: Clinical characteristics, proposed pathogenesis and potential therapeutic targets
Grace Kenny, Liam Townsend, Stefano Savinelli, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 34
Grace Kenny, Liam Townsend, Stefano Savinelli, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 34
Biological mechanisms underpinning the development of long COVID
Rubeshan Perumal, Letitia Shunmugam, Kogieleum Naidoo, et al.
iScience (2023) Vol. 26, Iss. 6, pp. 106935-106935
Open Access | Times Cited: 19
Rubeshan Perumal, Letitia Shunmugam, Kogieleum Naidoo, et al.
iScience (2023) Vol. 26, Iss. 6, pp. 106935-106935
Open Access | Times Cited: 19
Epstein Barr Virus Reactivation during COVID-19 Hospitalization Significantly Increased Mortality/Death in SARS-CoV-2(+)/EBV(+) than SARS-CoV-2(+)/EBV(−) Patients: A Comparative Meta-Analysis
Sivananthan Manoharan, Lee Ying Ying
International Journal of Clinical Practice (2023) Vol. 2023, pp. 1-8
Open Access | Times Cited: 18
Sivananthan Manoharan, Lee Ying Ying
International Journal of Clinical Practice (2023) Vol. 2023, pp. 1-8
Open Access | Times Cited: 18
Mechanisms of long COVID: An updated review
Yan Liu, Xiaoying Gu, Haibo Li, et al.
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2023) Vol. 1, Iss. 4, pp. 231-240
Open Access | Times Cited: 15
Yan Liu, Xiaoying Gu, Haibo Li, et al.
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2023) Vol. 1, Iss. 4, pp. 231-240
Open Access | Times Cited: 15
Cognitive Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome—Aetiology and Potential Treatments
Amolak S. Bansal, Katharine A. Seton, J.C. Brooks, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1896-1896
Open Access
Amolak S. Bansal, Katharine A. Seton, J.C. Brooks, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1896-1896
Open Access
Long COVID and rheumatology: Clinical, diagnostic, and therapeutic implications
Cassandra Calabrese, E. Kirchner, Leonard H. Calabrese
Best Practice & Research Clinical Rheumatology (2022) Vol. 36, Iss. 4, pp. 101794-101794
Open Access | Times Cited: 22
Cassandra Calabrese, E. Kirchner, Leonard H. Calabrese
Best Practice & Research Clinical Rheumatology (2022) Vol. 36, Iss. 4, pp. 101794-101794
Open Access | Times Cited: 22
Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV® Active Ingredients
Camille Jacques, Flora Marchand, Mathias Chatelais, et al.
Life (2024) Vol. 14, Iss. 1, pp. 102-102
Open Access | Times Cited: 3
Camille Jacques, Flora Marchand, Mathias Chatelais, et al.
Life (2024) Vol. 14, Iss. 1, pp. 102-102
Open Access | Times Cited: 3
Investigating viral and autoimmune T cell responses associated with post-acute sequelae of COVID-19
Gregory P. Williams, Esther Dawen Yu, K. I. Shapiro, et al.
Human Immunology (2024) Vol. 85, Iss. 3, pp. 110770-110770
Closed Access | Times Cited: 3
Gregory P. Williams, Esther Dawen Yu, K. I. Shapiro, et al.
Human Immunology (2024) Vol. 85, Iss. 3, pp. 110770-110770
Closed Access | Times Cited: 3
Antidepressants with anti-inflammatory properties may be useful in long COVID depression
Caroline Fenton, Arnold Lee
Drugs & Therapy Perspectives (2022) Vol. 39, Iss. 2, pp. 65-70
Open Access | Times Cited: 15
Caroline Fenton, Arnold Lee
Drugs & Therapy Perspectives (2022) Vol. 39, Iss. 2, pp. 65-70
Open Access | Times Cited: 15
Long-Term Symptoms after Mild Coronavirus Disease in Healthy Healthcare Professionals: A 12-Month Prospective Cohort Study
Grazielle Rosa da Costa e Silva, Winny Éveny Alves Moura, Kamila Cardoso dos Santos, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 2, pp. 1483-1483
Open Access | Times Cited: 8
Grazielle Rosa da Costa e Silva, Winny Éveny Alves Moura, Kamila Cardoso dos Santos, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 2, pp. 1483-1483
Open Access | Times Cited: 8
Relationship of quercetin intake and oxidative stress in persistent COVID
Diana Matías-Pérez, Carolina Antonio-Estrada, Araceli Guerra-Martínez, et al.
Frontiers in Nutrition (2024) Vol. 10
Open Access | Times Cited: 2
Diana Matías-Pérez, Carolina Antonio-Estrada, Araceli Guerra-Martínez, et al.
Frontiers in Nutrition (2024) Vol. 10
Open Access | Times Cited: 2
Towards understanding post-COVID-19 condition: A systematic meta-analysis of transcriptomic alterations with sex-specific insights
Elena Cristina Rusu, Pablo Monfort-Lanzas, Laia Bertran, et al.
Computers in Biology and Medicine (2024) Vol. 175, pp. 108507-108507
Open Access | Times Cited: 2
Elena Cristina Rusu, Pablo Monfort-Lanzas, Laia Bertran, et al.
Computers in Biology and Medicine (2024) Vol. 175, pp. 108507-108507
Open Access | Times Cited: 2
Etiopathogenic theories about long COVID
Luis Del Carpio-Orantes
World Journal of Virology (2023) Vol. 12, Iss. 3, pp. 204-208
Open Access | Times Cited: 7
Luis Del Carpio-Orantes
World Journal of Virology (2023) Vol. 12, Iss. 3, pp. 204-208
Open Access | Times Cited: 7
Intrinsic factors behind long COVID: III. Persistence of SARS‐CoV‐2 and its components
Nawal Abd El‐Baky, Amro Abd Al Fattah Amara, Vladimir N. Uversky, et al.
Journal of Cellular Biochemistry (2023) Vol. 125, Iss. 1
Closed Access | Times Cited: 7
Nawal Abd El‐Baky, Amro Abd Al Fattah Amara, Vladimir N. Uversky, et al.
Journal of Cellular Biochemistry (2023) Vol. 125, Iss. 1
Closed Access | Times Cited: 7
COVID-19, SARS-CoV-2 Vaccination, and Human Herpesviruses Infections
P.A.C. Maple
Vaccines (2023) Vol. 11, Iss. 2, pp. 232-232
Open Access | Times Cited: 6
P.A.C. Maple
Vaccines (2023) Vol. 11, Iss. 2, pp. 232-232
Open Access | Times Cited: 6
Role of the SARS-CoV-2 Virus in Brain Cells
Ali Azargoonjahromi
Viral Immunology (2024) Vol. 37, Iss. 2, pp. 61-78
Closed Access | Times Cited: 1
Ali Azargoonjahromi
Viral Immunology (2024) Vol. 37, Iss. 2, pp. 61-78
Closed Access | Times Cited: 1
Reactivation of Epstein–Barr virus among intensive care patients: a prospective observational study
François Guiouillier, Jean Derely, A. Salvadori, et al.
Intensive Care Medicine (2024) Vol. 50, Iss. 3, pp. 418-426
Closed Access | Times Cited: 1
François Guiouillier, Jean Derely, A. Salvadori, et al.
Intensive Care Medicine (2024) Vol. 50, Iss. 3, pp. 418-426
Closed Access | Times Cited: 1
Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV
Samuel R Schnittman, Wonyeong Jung, Kathleen V. Fitch, et al.
JCI Insight (2023) Vol. 8, Iss. 5
Open Access | Times Cited: 3
Samuel R Schnittman, Wonyeong Jung, Kathleen V. Fitch, et al.
JCI Insight (2023) Vol. 8, Iss. 5
Open Access | Times Cited: 3
The Role of VSL#3® in the Treatment of Fatigue and Other Symptoms in Long Covid-19 Syndrome: a Randomized, Double-blind, Placebo-controlled Pilot Study (DELong#3)
Beatrice Marinoni, Alessandro Rimondi, Federico Bottaro, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Beatrice Marinoni, Alessandro Rimondi, Federico Bottaro, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Long COVID in children: frequency and diagnostic challenges
L.A. Volianska, E.I. Burbela, Vita Perestiuk, et al.
Ukrainian journal of Perinatology and Pediatrics (2023), Iss. 3(95), pp. 101-106
Open Access | Times Cited: 2
L.A. Volianska, E.I. Burbela, Vita Perestiuk, et al.
Ukrainian journal of Perinatology and Pediatrics (2023), Iss. 3(95), pp. 101-106
Open Access | Times Cited: 2
Infectious complications of the respiratory tract and lungs in patients with post-COVID syndrome
О.К. Yakovenko, М.І. Lynnyk, V. І. Ignatieva, et al.
Infusion & Chemotherapy (2022), Iss. 4, pp. 20-29
Open Access | Times Cited: 4
О.К. Yakovenko, М.І. Lynnyk, V. І. Ignatieva, et al.
Infusion & Chemotherapy (2022), Iss. 4, pp. 20-29
Open Access | Times Cited: 4